CONTACT For sales and marketing info, to place an order for an UltraScan 650, or to discuss potential investment and licensing, please contact: Jonathan J. Kaufman, Ph.D. President & CEO CyberLogic, Inc. 611 Broadway, Suite 707 New York, NY 10012 CYBERLOGIC®, INC. CyberLogic is a research and development firm in New York City (corner of Broadway and Houston Street, see image), founded in 1992. CyberLogic has been working in the field of biomedical ultrasound for over 20 years. 212-260-1351 (Voice) 212-260-1353 (Fax) [email protected] http://www.cyberlogic.org U.S. FDA approval (510(k) summary1) can be found at: https://www.accessdata.fda.g ov/cdrh_docs/pdf16/K161919. pdf The UltraScan 650 is protected by several U.S. and international patents, including U.S. Patent Nos. 7,862,510, 8,202,219, and 9,039,616, and China Patent No. ZL2008 1 0004839.7, among others. The UltraScan 650 has been developed with peer-reviewed funding from the Small Business Innovative Research (SBIR) program of the National Institutes of Health. The radiation-free alternative to DXA, with the only FDAapproved bone sonometer to measure bone mineral density (BMD).

The UltraScan 650 • is an ultrasound device designed to non-invasively and quantitatively assess the amount of bone at the 1/3 location of the radius in the forearm of an individual. • is designed for the estimation of bone mineral density (BMD in g/cm2) of the radius at the 1/3 radius. • outputs a BMDus Index, an estimate of BMD that would be measured by DXA at the same anatomical location, that is, an estimate of BMDdxa, at the 1/3 radius. • outputs the T-score and z-score in standard deviations (SD). • has a precision of 2.1%. • Ten (10) second test • Convenient anatomical location (forearm) •...